AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Navigating Unchartered Waters: Managing Autoimmune and Inflammatory Skin Disorders in Pregnant and Breastfeeding Patients

Description

The session titled "Navigating Unchartered Waters" focuses on managing autoimmune and inflammatory skin disorders in pregnant and breastfeeding patients. Led by dermatologists Katarina Shaw and maternal-fetal medicine specialist Nicole Smith, the discussion emphasizes the complexities of treating conditions like lupus and dermatomyositis during pregnancy. They highlight the typical challenges dermatologists face when balancing effective treatment with the safety of both the mother and fetus. Key points include the recognition that limiting medications during pregnancy can sometimes worsen patient health and lead to greater risks for the fetus. The presentation uses case studies to illustrate clinical decision-making processes, including the evaluation of medication risks versus the consequences of untreated disease. Furthermore, it discusses the pharmacokinetics of drug transfer through pregnancy and lactation, emphasizing the importance of continuing certain treatments that are safe for breastfeeding while considering the long-term health benefits of breastfeeding for both mother and child. The session ultimately urges interdisciplinary collaboration to provide optimal care for patients and their families, underlining the necessity for healthcare providers to remain informed about the evolving landscape of safe treatment options in pregnancy.

View more

Conclusions

  • Dermatologists should be cautious but manage autoimmune and inflammatory skin disorders in pregnant and breastfeeding patients without unnecessary medication withdrawal.
  • Consultation with maternal-fetal medicine specialists can help optimize care for pregnant patients with complex autoimmune conditions.
  • Topical corticosteroids are generally safe in pregnancy, and their use should not be avoided due to outdated concerns about risks such as cleft lip or palate.
  • Systemic treatments for rheumatologic diseases during pregnancy, such as methotrexate and mycophenolate, should be avoided due to teratogenic risks.
  • Biologics such as TNF inhibitors and rituximab have no evidence of fetal harm and may be continued during pregnancy, although individual assessment is necessary.
  • The risks of untreated autoimmune disease may outweigh the potential risks of certain medications during pregnancy.
  • Breastfeeding should be encouraged for its long-term maternal and infant health benefits, and treatment options should be compatible with lactation whenever possible.
  • Health care professionals must prioritize both maternal and fetal health in treatment decisions for pregnant and breastfeeding patients with autoimmune and inflammatory skin diseases.
  • Abu-Raya et al. Maternal Immunological Adaptation During Normal Pregnancy, Frontiers in Immunology, 2022
  • Niklas Worm Andersson, MD; Lone Skov, MD, PhD; Jon Trærup Andersen, MD, PhD. Evaluation of Topical Corticosteroid Use in Pregnancy and Risk of Newborns Being Small for Gestational Age and Having Low Birth Weight. JAMA Dermatology, 2021;157(7):788-795. doi:10.1001/jamadermatol.2021.1090
  • Bandoli et al. A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes. Rheum Dis Clin North Am. 2017 Aug;43(3):489-502.
  • van Runnard Heimel PJ, Franx A, Schobben AF, Huisjes AJ, Derks JB, Bruinse HW. Corticosteroids, pregnancy, and HELLP syndrome: a review. Obstet Gynecol Surv. 2005;60(1):57-70.
  • Morand EF, et al; TULIP-2 Trial Investigators. Trial of Anifrolumab in Active Systemic Lupus Erythematosus. N Engl J Med. 2020 Jan 16;382(3):211-221.
  • Schwartz Am J Med 2010
  • Lena Tschiderer, Lisa Seekircher, Setor K. Kunutsor, Sanne A. E. Peters, Linda M. O'Keeffe and Peter Willeit. Breastfeeding Is Associated With a Reduced Maternal Cardiovascular Risk: Systematic Review and Meta-Analysis. Journal of the American Heart Association. 2022;11:e022746.
  • Silveira Lessa, A. L., Krebs, V. L., Brasil, T. B. et al. Preterm and term neonates transplacentally acquire IgG antibodies specific to LPS from Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa. FEMS Immunology and Medical Microbiology, vol. 62, no. 2, pp. 236-243, 2011.